I-Mab Biopharma
IMAB
#9469
Rank
โ‚น4.73 B
Marketcap
โ‚น58.13
Share price
-6.87%
Change (1 day)
-61.32%
Change (1 year)

Earnings for I-Mab Biopharma (IMAB)

Earnings in 2024 (TTM): -โ‚น16.41 Billion

According to I-Mab Biopharma's latest financial reports the company's current earnings are โ‚น3.58 Million. In 2023 the company made an earning of -โ‚น2.5 Billion, an increase over its 2022 earnings that were of -โ‚น4.51 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for I-Mab Biopharma from 2017 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น16.41 Billion556.53%
2023 -โ‚น2.5 Billion-44.5%
2022-โ‚น4.51 Billion-8.36%
2021-โ‚น4.92 Billion-605.96%
2020 โ‚น0.97 B-138.32%
2019 -โ‚น2.54 Billion260.14%
2018 -โ‚น0.71 Billion19.49%
2017-โ‚น0.59 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น1.56 Billion-90.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น0.89 Billion-94.74%๐Ÿ‡บ๐Ÿ‡ธ USA